© 2026 NervNow™. All rights reserved.
Harbour BioMed’s AI Drug LET003 Shows Strong Obesity Preclinical Results

Harbour BioMed's AI-designed antibody LET003 outperforms rival molecules in preclinical tests, boosting fat loss while protecting muscle when paired with semaglutide.














